AIN

Over the past six months, Albany International reported strong Q2 2026 earnings with increased revenue, EPS, and adjusted EBITDA, likely positively impacting the stock. The announcement of the CFO's medical leave introduced some uncertainty. The company completed a strategic review of its Salt Lake City facility, deciding to retain it after securing amended contract terms and new business, which led to a 10.7% jump in shares and boosted Q3 2026 adjusted EPS guidance. Albany Engineered Composites secured a Boeing 787 contract extension and a $21.2 million IBAS contract for hypersonic and solid rocket motor thermal protection, contributing positively to investor confidence. The company declared a quarterly dividend of $0.28 per share, which generally supports investor interest. Analyst activities were mixed, with Wall Street Zen upgrading to 'buy' and JPMorgan Chase & Co. increasing its price objective, while Weiss Ratings cut shares to 'sell'.